DANIELLE LECLAIR

Department of Defense peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year 2006. Sent letter to Defense Appropriations Conferees supporting this program. Meetings with key congressional staff regarding program. Enactment of S.757/H.R.2231, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosponsorship. Phoned Members of Congress urging cosponsorship. Enactment of S.470, the Fair Access to Clinical Trials Act. Meetings and calls with key congressional staff regarding cosponsorship. Preventing cuts to Medicaid. Conducted meetings and calls, and wrote letters to Congress urging them to oppose cuts to Medicaid.

Department of Defense peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year 2006. Sent letter to Defense Appropriations Conferees supporting this program. Meetings with key congressional staff regarding program. Enactment of S.757/H.R.2231, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosponsorship. Phoned Members of Congress urging cosponsorship. Enactment of S.470, the Fair Access to Clinical Trials Act. Meetings and calls with key congressional staff regarding cosponsorship. Preventing cuts to Medicaid. Conducted meetings and calls, and wrote letters to Congress urging them to oppose cuts to Medicaid.

Department of Defense peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year 2006. Sent letter to Defense Appropriations Conferees supporting this program. Meetings with key congressional staff regarding program. Enactment of S.757/H.R.2231, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosponsorship. Phoned Members of Congress urging cosponsorship. Enactment of S.470, the Fair Access to Clinical Trials Act. Meetings and calls with key congressional staff regarding cosponsorship. Preventing cuts to Medicaid. Conducted meetings and calls, and wrote letters to Congress urging them to oppose cuts to Medicaid.

Department of Defense peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year 2006. Sent letter to Defense Appropriations Conferees supporting this program. Meetings with key congressional staff regarding program. Enactment of S.757/H.R.2231, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosponsorship. Phoned Members of Congress urging cosponsorship. Enactment of S.470, the Fair Access to Clinical Trials Act. Meetings and calls with key congressional staff regarding cosponsorship. Preventing cuts to Medicaid. Conducted meetings and calls, and wrote letters to Congress urging them to oppose cuts to Medicaid.

Guaranteed access to quality health care for all. Letter to Medicare conferees regarding NBCC principles for quality care. Department of Defense (DoD) peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year (FY) 2004. Enactment of S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosposorship. Phoned Members of Congress urging cosponsorship. Enactment of H.R. 1910, the Genetic Nondiscrimination in Health Insurance and Employment Act with strong enforcement provisions as defined by NBCC. Sent letters to Members of Congress urging strong enforcement provisions and floor statements. Oral anti-cancer medication demonstration program under Medicare. Wrote letter to Secretary of Health and Human Services and to the CMS Administrator urging them to include tamoxifen and other breast cancer treatments in this demonstration program.

Guaranteed access to quality health care for all. Letter to Medicare conferees regarding NBCC principles for quality care. Department of Defense (DoD) peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year (FY) 2004. Enactment of S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosposorship. Phoned Members of Congress urging cosponsorship. Enactment of H.R. 1910, the Genetic Nondiscrimination in Health Insurance and Employment Act with strong enforcement provisions as defined by NBCC. Sent letters to Members of Congress urging strong enforcement provisions and floor statements. Oral anti-cancer medication demonstration program under Medicare. Wrote letter to Secretary of Health and Human Services and to the CMS Administrator urging them to include tamoxifen and other breast cancer treatments in this demonstration program.

Guaranteed access to quality health care for all. Letter to Medicare conferees regarding NBCC principles for quality care. Department of Defense (DoD) peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year (FY) 2004. Enactment of S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosposorship. Phoned Members of Congress urging cosponsorship. Enactment of H.R. 1910, the Genetic Nondiscrimination in Health Insurance and Employment Act with strong enforcement provisions as defined by NBCC. Sent letters to Members of Congress urging strong enforcement provisions and floor statements. Oral anti-cancer medication demonstration program under Medicare. Wrote letter to Secretary of Health and Human Services and to the CMS Administrator urging them to include tamoxifen and other breast cancer treatments in this demonstration program.

Guaranteed access to quality health care for all. Letter to Medicare conferees regarding NBCC principles for quality care. Department of Defense (DoD) peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year (FY) 2004. Enactment of S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosposorship. Phoned Members of Congress urging cosponsorship. Enactment of H.R. 1910, the Genetic Nondiscrimination in Health Insurance and Employment Act with strong enforcement provisions as defined by NBCC. Sent letters to Members of Congress urging strong enforcement provisions and floor statements. Oral anti-cancer medication demonstration program under Medicare. Wrote letter to Secretary of Health and Human Services and to the CMS Administrator urging them to include tamoxifen and other breast cancer treatments in this demonstration program.

Guaranteed access to quality health care for all. Letter to Medicare conferees regarding NBCC principles for quality care. Department of Defense (DoD) peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year (FY) 2004. Enactment of S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosposorship. Phoned Members of Congress urging cosponsorship. Enactment of H.R. 1910, the Genetic Nondiscrimination in Health Insurance and Employment Act with strong enforcement provisions as defined by NBCC. Sent letters to Members of Congress urging strong enforcement provisions and floor statements. Oral anti-cancer medication demonstration program under Medicare. Wrote letter to Secretary of Health and Human Services and to the CMS Administrator urging them to include tamoxifen and other breast cancer treatments in this demonstration program.

Guaranteed access to quality health care for all. Letter to Medicare conferees regarding NBCC principles for quality care. Department of Defense (DoD) peer-reviewed Breast Cancer Research Program (BCRP) for fiscal year (FY) 2004. Enactment of S. 983/H.R. 1746, the Breast Cancer and Environmental Research Act. Meetings with key congressional staff regarding cosposorship. Phoned Members of Congress urging cosponsorship. Enactment of H.R. 1910, the Genetic Nondiscrimination in Health Insurance and Employment Act with strong enforcement provisions as defined by NBCC. Sent letters to Members of Congress urging strong enforcement provisions and floor statements. Oral anti-cancer medication demonstration program under Medicare. Wrote letter to Secretary of Health and Human Services and to the CMS Administrator urging them to include tamoxifen and other breast cancer treatments in this demonstration program.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.

Department of Defense Breast Cancer Research Program Dear Colleague letter to the Chairman of the Appropriations Defense Subcommittee in support of level funding of $175 million for the Department of Defense Breast Cancer Research Program. The Breast and Cervical Cancer Treatment Act H.R. 1070, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” S. 662, Breast and Cervical Cancer Treatment Act of 1999, Section 1, “Optional Medicaid coverage of certain breast or cervical cancer patients.” Breast Cancer and Environmental Research Act of 1999 H.R. 3433 / S. 2287, Breast Cancer and Environmental Research Act of 1999, Section 3, Amendments to Subpart 12 of part C of title IV of the Public Health Service Act that add research centers regarding environmental factors related to breast cancer. Medicare Cancer Clinical Trial Coverage Act of 1999 H.R. 1388, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing “a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program” S. 784, Medicare Cancer Clinical Trial Coverage Act of 1999, all provisions related to establishing a demonstration project to study and provide coverage of routine patient care costs for Medicare beneficiaries with cancer who are enrolled in an approved clinical trial program Genetic Nondiscrimination Legislation H.R. 306, Genetic Information Nondiscrimination in Health Insurance Act of 1999, Section 2, Amendments to Employee Retirement Income Security Act of 1974; Subsection 714 Prohibition of health insurance discrimination on the basis of genetic information and Section 3 Amendments to the Public Health Service Act, Subsection 9814, Prohibition of discrimination by group health plans on the basis of genetic information. H.R. 2457 / S. 1322, Genetic Nondiscrimination in Health Insurance and Employment Act of 1999, Title I, all provisions relating to the prohibition of health insurance discrimination on the basis of predictive genetic information; Title II, all provisions relating to the prohibition of employment discrimination on the basis of predictive genetic information. Patients’ Bill of Rights: H.R. 2723, The Bipartisan Consensus Managed Care Act of 1999, Title I, Subtitle A – Grievance and Appeals, improving managed care through internal and external appeals processes; Subtitle B – Access to Care, Sec. 114 – providing for access to specialty care, Sec. 117 – providing for continuity of care, and Sec. 119 – providing for individuals participating in approved clinical trials. S. 6, Patients’ Bill of Rights Act of 1999, Subtitle A, all provisions relating to access to care specifically, Section 106, coverage for individuals participating in approved clinical trials and Section 105, continuity of care provisions. Also Subtitle F, Section 152, “standards relating to benefits for certain breast cancer treatment” and Subtitle D, grievance and appeals procedures.